Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Japan Tissue Engineering Co's share price is 円621.00.
Japan Tissue Engineering Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円53.75. Hence, Japan Tissue Engineering Co's PS Ratio for today is 11.55.
The historical rank and industry rank for Japan Tissue Engineering Co's PS Ratio or its related term are showing as below:
TSE:7774'
s PS Ratio Range Over the Past 10 Years
Min: 6.78 Med: 11.85 Max: 43.65
Current: 11.55
During the past 13 years, Japan Tissue Engineering Co's highest PS Ratio was 43.65. The lowest was 6.78. And the median was 11.85.
TSE:7774's PS Ratio is ranked worse than 55.81% of 930
companies
in the Biotechnology industry
Industry Median: 9.3
vs TSE:7774: 11.55
Japan Tissue Engineering Co Ltd revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Japan Tissue Engineering Co was -11.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 2.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 1.50% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 2.40% per year.
During the past 13 years, Japan Tissue Engineering Co's highest 3-Year average Revenue per Share Growth Rate was 39.10% per year. The lowest was -4.20% per year. And the median was 15.55% per year.
Back to Basics: PS Ratio
Japan Tissue Engineering Co (TSE:7774) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Japan Tissue Engineering Co PS Ratio Related Terms
Japan Tissue Engineering Co PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Japan Tissue Engineering Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Japan Tissue Engineering Co PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Japan Tissue Engineering Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Japan Tissue Engineering Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Japan Tissue Engineering Co's Share Price of today is 円621.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Japan Tissue Engineering Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円53.75.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Japan Tissue Engineering Co (TSE:7774) has a PS Ratio of 11.55 as of Jul. 18, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Japan Tissue Engineering Co and its competitors. This is near median its historical median of 11.85. Over the past decade, Japan Tissue Engineering Co's PS Ratio has ranged from 6.78 to 43.65. According to the industry distribution chart, Japan Tissue Engineering Co ranks #519 out of 930 companies in the Biotechnology industry, placing it in the top 55.8%.
Is Japan Tissue Engineering Co's PS Ratio too high?
Japan Tissue Engineering Co's current PS Ratio of 11.55 is near median its 10-year median of 11.85. Over the past 10 years, this metric has ranged from a low of 6.78 to a high of 43.65. The Biotechnology industry median PS Ratio is 9.30. Japan Tissue Engineering Co's value of 11.55 is 24.2% above this industry median. Based on the distribution chart, Japan Tissue Engineering Co ranks #519 out of 930 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Japan Tissue Engineering Co has a GF Score™ of 61/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Japan Tissue Engineering Co's PS Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Japan Tissue Engineering Co ranks #519 out of 930 companies for PS Ratio. This places Japan Tissue Engineering Co in the lower half of its industry. The industry median PS Ratio is 9.30. Japan Tissue Engineering Co's value of 11.55 is 24.2% above this benchmark. Historically, Japan Tissue Engineering Co's own PS Ratio has ranged from 6.78 to 43.65 over the past decade. While the company's 10-year median is 11.85 vs. the industry median of 9.30, Japan Tissue Engineering Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.30, based on 930 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Japan Tissue Engineering Co's current PS Ratio of 11.55 is 24.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Japan Tissue Engineering Co and its competitors. For the Biotechnology industry, the median PS Ratio is 9.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Japan Tissue Engineering Co's current PS Ratio is 11.55, which is near median its own 10-year median of 11.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Tissue Engineering Co stock overvalued right now?
Based on GuruFocus' analysis, Japan Tissue Engineering Co (TSE:7774) is currently considered Modestly Overvalued. The stock's GF Value™ is 円517.48, compared to a current price of 円621.00 — trading 20% above its estimated fair value. The current PS Ratio is 11.55, which is near median its 10-year median of 11.85 and 24.2% above the Biotechnology industry median of 9.30. Japan Tissue Engineering Co's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Japan Tissue Engineering Co (TSE:7774), the current PS Ratio is 11.55 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Japan Tissue Engineering Co (TSE:7774) Overvalued in 2026?
Based on GuruFocus' analysis, Japan Tissue Engineering Co stock appears to be overvalued.
The current stock price of 円621.00 is trading 20% above its estimated GF Value™ of 円517.48.
GuruFocus considers Japan Tissue Engineering Co to be Modestly Overvalued.
Key valuation signals for TSE:7774:
PS Ratio: 11.55 (near median its 10-year median of 11.85)
GF Value™: 円517.48 vs. price of 円621.00 (20% above fair value)
Industry Position: 24.2% above the Biotechnology median (#519 of 930)
No single metric tells the full story. See the TSE:7774 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Japan Tissue Engineering Co Ltd is a bio-venture enterprise. It is engaged in the development, manufacture, and sale of tissue-engineered medical products and related products. It operates through the Regenerative Medicine, and Research and Development support business segments. The main business goal is to use autologous culturing techniques to develop tissue-engineered medical products and then to manufacture and sell these same tissue-engineered products to medical institutions for medical treatment. The company's tissue-engineered medical products are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured and then transplanted back to that same patient.
61GF Score
Get the complete analysis for TSE:7774
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7774 has been successfully added to your 
